1 active not recruiting, 1 enrolling by invitation, 1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
Follow Reticular dysgenesis: new trials by email Literature Review of Reticular dysgenesis trials Research Report on Reticular dysgenesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan - SCID, Omenn's Syndrome | Not applicable | Active not recruiting | Masonic Cancer Center, University of Minnesota | 57 | 2012-09-04 | 2026-06-17 |
| Patients Treated for SCID (1968-Present) SCID, ADA-SCID | Unknown | National Institute of Allergy and Infectious Diseases (NIAID) | 1007 | 2011-05-15 | 2020-11-12 | |
| Natural History Study of SCID Disorders Severe Combined Immunodeficiency (SCID), Leaky SCID | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 690 | 2010-09-02 | 2020-11-10 |
Severe Combined Immunodeficiency (3) · Severe combined immunodeficiency due to adenosine deaminase deficiency (2) · X-Linked Combined Immunodeficiency Diseases (2) · Chediak-Higashi Syndrome (1) · Common Variable Immunodeficiency (1) · Granulomatous Disease, Chronic (1) · Histiocytosis, Langerhans-Cell (1) · Hyper-IgM Immunodeficiency Syndrome (1) · Immunologic Deficiency Syndromes (1) · Lymphohistiocytosis, Hemophagocytic (1) · Lymphoproliferative Disorders (1) · Wiskott-Aldrich Syndrome (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · DNA Repair-Deficiency Disorders (3) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Immune System Diseases (3) · Infant, Newborn, Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Primary Immunodeficiency Diseases (3) · Immunologic Deficiency Syndromes (2) · Albinism (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Blood Protein Disorders (1) · Chronic Disease (1)
Alemtuzumab (1) · Busulfan (1) · Cyclophosphamide (1) · Melphalan (1) · Mesna (1) · Sodium (1) · Stem Cell Transplantation (1) · fludarabine phosphate (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Masonic Cancer Center, University of Minnesota (1)
United States (3) · Canada (2)
Morton J. Cowan, MD (2) · Christopher C. Dvorak, MD (1) · Elie Haddad, MD, PhD (1) · Meera Srikanthan, MD (1) · Richard J. O'Reilly, MD (1)
PMID 20004776, PMID 23818196, PMID 24139498, PMID 24290292, PMID 24331379, PMID 25075835, PMID 27262745, PMID 30193840, PMID 35671392, PMID 41289158, PMID 29021228, PMID 29728406, PMID 30154114, PMID 30194989, PMID 33006109